By admin 
In a significant stride toward addressing this challenge, researchers led by Professor Ryuichi Tatsumi of Kyushu University’s Faculty of Agriculture have identified a novel molecule that shows remarkable promise in protecting and enhancing a crucial signaling pathway involved in skeletal muscle repair and regeneration. Their groundbreaking findings, published on July 24, 2026, in the esteemed journal Scientific Reports, shed new light on the intricate processes governing muscle health and offer a potential therapeutic avenue for combating age-related muscle decline.
The Intricate Mechanism of Muscle Repair and Its Vulnerability in Aging
At the heart of this research lies hepatocyte growth factor, or HGF, a pleiotropic protein renowned for its diverse biological roles, particularly its indispensable function in initiating the repair and regeneration of skeletal muscle. Under normal physiological conditions, HGF does not freely circulate in its active form. Instead, it remains quiescent, bound and inactive within the structural network of proteins and carbohydrates that constitute the extracellular matrix (ECM) surrounding muscle fibers. This strategic sequestration ensures that HGF is only deployed when its reparative capabilities are truly needed.
The body’s sophisticated repair system is triggered by specific cues. When muscle tissue sustains injury – whether from trauma, overuse, or even the subtle micro-damage induced by mechanical stimulation during exercise – HGF is precisely released from its ECM anchors. Once liberated, this critical protein embarks on its mission by attaching to its cognate receptor, c-Met, which is predominantly expressed on the surface of satellite cells. Satellite cells are the undisputed guardians of skeletal muscle integrity; these remarkable adult stem cells lie dormant, nestled beneath the basal lamina of muscle fibers, poised for action. The binding of HGF to c-Met acts as a potent "wake-up call," signaling these quiescent satellite cells to exit their inactive state. This activation initiates a cascade of events: the cells begin to multiply rapidly (proliferate), then mature into specialized muscle-forming cells (myoblasts), and finally fuse together to form new muscle fibers or contribute to the repair of existing damaged ones. This HGF-c-Met axis is therefore fundamental for maintaining muscle mass, facilitating recovery from injury, and enabling adaptive responses to exercise throughout life.
However, the efficiency of this meticulously orchestrated repair system is regrettably compromised with advancing age. Aging is characterized by an increase in systemic oxidative stress and inflammation, creating an environment where delicate proteins like HGF become vulnerable to damaging chemical modifications. Previous research from Professor Tatsumi’s team, highlighted by a study published in Aging Cell (http://doi.org/10.1111/acel.14041), meticulously detailed one such detrimental modification: HGF can undergo a process known as nitration. During this chemical alteration, a nitro group is covalently added to two specific tyrosine residues on the HGF protein: Y198 and Y250. Crucially, these two sites are strategically located within the very region of HGF responsible for its interaction and binding with the c-Met receptor.
The consequences of this nitration are severe. Once nitrated, HGF’s three-dimensional structure is subtly altered, rendering it unable to attach effectively or efficiently to the c-Met receptor. Professor Tatsumi aptly likens this compromised protein to a "rusted key that no longer fits its lock." This analogy powerfully illustrates the functional impairment: the key (HGF) is still present, but its ability to unlock the cellular repair machinery (c-Met receptor on satellite cells) is severely diminished. This loss of HGF function due to nitration is now strongly implicated as one of the fundamental underlying causes of muscle wasting (sarcopenia) and the observed reduction in muscle regeneration capacity commonly seen in older adults. It elucidates why, even in the presence of HGF, the muscle repair process falters with age.
"HGF is not necessarily missing as we age," explains Tatsumi, underscoring a critical distinction. "Rather, it can be chemically altered after it is made. That led us to wonder whether a compound with strong antioxidant capacity might protect HGF, either by preventing nitration or by compensating for the functional loss it causes." This pivotal hypothesis formed the bedrock of their subsequent investigations, driving the search for molecules capable of restoring or enhancing HGF’s vital role.
Investigating the Potential of Sulfur-Based Antioxidants
Guided by this hypothesis, the scientists turned their attention to a specific class of compounds known for their robust antioxidant properties and unique chemical structures: trisulfides. They meticulously investigated two such compounds: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS). Both molecules belong to the trisulfide family, characterized by the presence of three sulfur atoms connected in sequence within their molecular backbone. This distinctive sulfur chemistry is particularly intriguing in biochemical contexts, as sulfur atoms can participate in a variety of redox reactions, making them potent players in cellular defense against oxidative stress.
Trisulfides have garnered increasing interest in pharmaceutical research precisely because of these unique properties. Their ability to act as powerful electron donors and acceptors enables them to neutralize reactive oxygen and nitrogen species (RONS), which are abundant in conditions of oxidative stress and are responsible for damaging molecules like HGF. By scavenging these harmful radicals, trisulfides could theoretically prevent or reverse the nitration of HGF, thereby preserving its functional integrity. The exploration of GSSSG and LASSS was thus a strategic move, targeting compounds with the potential to directly intervene in the age-related impairment of HGF.
Initial in vitro experiments, carefully designed to test the protective capacity of these compounds, yielded promising, albeit partial, results. The researchers observed that both GSSSG and LASSS effectively reduced the extent of nitration occurring at the critical Y198 and Y250 sites on the HGF protein. This confirmed their antioxidant activity and their ability to mitigate the chemical damage to HGF. However, a crucial observation emerged: while nitration was reduced, neither compound fully restored HGF’s ability to bind to its c-Met receptor to the levels seen in pristine, unnitrated HGF. This suggested that while preventing damage was beneficial, a more profound intervention might be needed to fully reclaim HGF’s functional capacity.
The Unexpected Breakthrough: LASSS Creates a Stronger HGF Signal
Undeterred by these initial limitations, the research team pushed further, exploring whether altering the concentration of the trisulfides relative to HGF could yield different outcomes. They increased the molar ratio of HGF to trisulfide, escalating from an initial 1:4000 to a significantly higher 1:8000. This seemingly minor adjustment in experimental design led to an utterly unexpected and profoundly significant discovery.
When HGF was incubated with the higher concentration of LASSS, its ability to bind to the c-Met receptor soared to more than twice that of untreated HGF. This was not merely a restoration of function but a remarkable enhancement, suggesting that LASSS was doing far more than simply preventing damage. Furthermore, the protein treated with LASSS became significantly more resistant to the functional loss typically caused by nitration, particularly at the Y198 site. This indicates a dual benefit: not only was HGF protected, but its intrinsic activity was also amplified.
Crucially, this extraordinary improvement was observed exclusively with LASSS. GSSSG, despite its similar antioxidant properties and trisulfide structure, did not produce the same enhancing effect on HGF’s binding affinity. This specificity strongly implied that the mechanism was not merely general antioxidant scavenging but involved a more direct and specific interaction between LASSS and HGF.
"This exceeded our expectations," comments Tatsumi, conveying the surprise and excitement within the research team. "We knew trisulfides had diverse biological functions, but we never expected that simply mixing HGF with LASSS would produce such a striking effect. What this tells us is that LASSS does more than simply neutralize reactive molecules. It may interact directly with HGF and induce a subtle structural change, creating an enhanced ‘Super HGF’ form that binds c-met more strongly and resists nitration."
This hypothesis represents a paradigm shift in understanding the interaction. Rather than acting solely as a passive antioxidant, LASSS appears to actively modulate the structure of HGF in a beneficial way. This direct interaction could lead to a conformational change in HGF, making its c-Met binding region more accessible or optimized for receptor engagement. The resulting "Super HGF" would therefore not only be more resilient to chemical damage but also inherently more potent in activating the muscle repair pathway. This discovery opens up entirely new avenues for therapeutic intervention, moving beyond mere protection to active enhancement of a vital regenerative protein.
Promising Results in a Mouse Model: Translating to Living Systems
To determine whether these remarkable protective and enhancing effects observed in vitro could be replicated in a living biological system, the team embarked on in vivo studies. They tested LASSS in a mouse model designed to mimic muscle atrophy, a condition closely related to sarcopenia and disuse atrophy. This was achieved through a well-established tail suspension procedure, which induces muscle disuse and atrophy in the hind limbs, mirroring aspects of prolonged bed rest or immobility.
The results from these animal studies were highly encouraging. Mice that received LASSS treatment prior to the tail suspension procedure exhibited significantly lower levels of HGF nitration in their muscle tissue compared to untreated control mice. This in vivo validation confirmed that LASSS could indeed protect HGF from oxidative damage within the complex environment of living tissue, reinforcing the findings from the laboratory experiments. Consistent with the in vitro observations, GSSSG once again failed to provide any measurable protection against HGF nitration in the living animals, further underscoring the unique efficacy of LASSS. These results provide critical evidence that the beneficial effects of LASSS are not limited to isolated proteins in a test tube but can manifest within a physiological context, making it a compelling candidate for further translational research.
However, the researchers are cautious and emphasize the necessary next steps. While promising, these initial in vivo studies were conducted on younger mice subjected to an acute atrophy model. To establish the safety and efficacy of LASSS as a therapeutic agent for age-related sarcopenia, additional, more extensive studies involving aging animals will be absolutely essential. These future investigations will need to meticulously assess long-term safety profiles, optimal dosing regimens, and the sustained effectiveness of LASSS in mitigating chronic muscle deterioration characteristic of natural aging.
A Possible Strategy for Preserving Muscle and Enhancing Healthspan
The discovery of LASSS’s unique capacity to protect and enhance HGF activity represents a significant leap forward in the quest to combat muscle deterioration. This finding could profoundly support the development of entirely new pharmacological approaches for maintaining muscle repair and regenerative capacity, not only during the natural aging process but also in other critical conditions that lead to muscle loss. These include extended periods of bed rest, such as those following surgery or chronic illness, and other scenarios involving prolonged physical inactivity, like space travel or sedentary lifestyles.
The researchers hypothesize that the beneficial effects of LASSS on HGF are likely to be conserved across multiple species, given the high evolutionary conservation of HGF and c-Met pathways. This broad applicability suggests that LASSS could potentially benefit not only humans but also companion animals such as cats and dogs, which also suffer from age-related muscle decline and conditions like cachexia.
Looking further into the future, the implications are substantial. By preserving and potentially enhancing the body’s innate muscle repair machinery, this approach could offer a powerful strategy to help people maintain vital physical strength, preserve their independence, and significantly improve their overall quality of life as they grow older. Ultimately, interventions that successfully combat sarcopenia have the potential to extend not just lifespan, but more importantly, healthspan – the period of life spent in good health, free from the debilitating effects of chronic diseases and functional limitations. This research marks a critical step towards realizing that ambitious goal, offering a beacon of hope for a future where healthy aging is a more attainable reality for all. Continued research into the precise mechanisms of LASSS’s action and its systemic effects will be crucial in moving this promising discovery from the laboratory bench to clinical application, paving the way for novel therapies against age-related muscle decline.
